StrainX Bioworks Secures $13M to Advance Synthetic Biology
India’s synthetic biology startup ecosystem has taken a significant leap forward with StrainX Bioworks emerging from stealth after securing $13 million in Series A funding co-led by Prime Venture Partners and Leo Capital .
This is not just another funding announcement; it signals a strategic maturation of the Indian biotech landscape—moving from pharmaceutical services towards building indigenous, deep-tech manufacturing capabilities in precision fermentation .
Read More